Brendan Michael McCracken - 31 Mar 2026 Form 4 Insider Report for Ovintiv Inc. (OVV)

Reporting relationship: President & CEO, Director
Issuer ticker: OVV
Reported as of: 31 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2026, 19:07:15 UTC
Prior SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Dawna Gibb, by Power of Attorney

Key filing fact

Brendan Michael McCracken filed Form 4 for Ovintiv Inc. (OVV) on 02 Apr 2026.

Key facts

This page summarizes Brendan Michael McCracken's Form 4 filing for Ovintiv Inc. (OVV).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Apr 2026, 19:07.

Change

Previous filing in this sequence was filed on 11 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001788621 Primary reporting owner

McCracken Brendan Michael

Relationship: President & CEO, Director
Address: C/O 370 17TH STREET, SUITE 1700, DENVER
Signature: /s/ Dawna Gibb, by Power of Attorney
Signature date: 02 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OVV transaction Derivative

Restricted Share Unit

Award

Transaction value
Shares: +1,109
Change %: +0.49%
Price: $0.000000^*
Shares after: 225,477
Date: 31 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,109
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Share Unit ("RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs, subject to the grantee's continued employment with Ovintiv through the applicable exercise date.

Footnote F2

Dividend equivalent RSUs received in lieu of cash dividends for the first quarter of 2026.